Category: news

Under the auspices of the Syrian Doctors Syndicate, the Syrian Orthopedic Association opened the annual scientific conference in the capital, Damascus, at the Sheraton Hotel, which included a number of axes to discuss the latest findings of orthopedic surgery in Syria. The conference brought together a large segment of Syrian doctors from all governorates in addition to doctors residing in hospitals. From this context, MAM International sought within this conference to present the latest and best scientific findings of drug treatments in this field, and we are pleased to be the first and only pharmaceutical company to provide a combination of chondroitin sulfate in the form of intramuscular injection, as the participation of MAM International in the conference was through MUCOSAT® is an effective and revolutionary treatment for degenerative diseases…

Joint pain is one of the diseases that many suffer from, and studies indicate that one in 5 people over forty-five years of age suffers from osteoarthritis symptoms, which is damage to the joint cartilage tissue that reduces friction resulting from joint movement. Permanent. Osteoarthritis is one of the most important reasons for determining movement, hence the importance of concerted efforts of experts in search of quality and advanced treatments to treat this disease and reduce its effects. In this context, MAM International sought to provide the best quality treatment options in this field, as MAM International recently launched a new drug in the Syrian market called Mucosat® as a revolutionary and patented treatment in a pharmaceutical form that helps to recover from osteoarthritis, protect cartilage, and treat pain in…